1.Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease.
Jose ILLNAIT ; Ivan RODRIGUEZ ; Sarahi MENDOZA ; Yolanda FERNANDEZ ; Rosa MAS ; Mirtha MIRANDA ; Jesus PINERA ; Julio Cesar FERNANDEZ ; Meilis MESA ; Lilia FERNANDEZ ; Daisy CARBAJAL ; Rafael GAMEZ
The Korean Journal of Internal Medicine 2013;28(4):439-448
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) is intimately related to insulin resistance and ranges from a benign course to liver fibrosis and cirrhosis. NAFLD management mainly involves dietary modification and weight loss. Although no fully successful pharmacological intervention is available, alternative therapies to treat NAFLD have shown promising results. Experimental studies have shown that D-002, a mixture of beeswax alcohols with antioxidant effects, is hepatoprotective. The aim of this study was to investigate the efficacy and safety of D-002 in patients with NALFD. METHODS: Fifty patients with NAFLD were randomized to receive a placebo or D-002 (100 mg/day) for 24 weeks. The primary endpoint was a significant ultrasonography-detected reduction of liver fat infiltration versus a placebo. Secondary endpoints were decreases in the homeostatic model assessment (HOMA) index, insulin levels, serum liver enzymes, increases in plasma total antioxidant status (TAS) and improved clinical symptoms versus the placebo recipients. RESULTS: At randomization, all indicators were comparable in both groups. At study completion, seven (28.0%) D-002-patients, but none of the placebo recipients, exhibited a normal liver echo pattern on ultrasonography (p < 0.01). Also, D-002 significantly reduced (p < 0.01 vs. baseline and placebo) the HOMA index and insulin levels and increased the TAS, but did not affect other parameters. The proportion of D-002-patients (12/25, 48.0%) showing symptom improvement was higher (p < 0.001) than that of the placebo group (1/25, 4.0%). The treatment was safe and well tolerated. Three patients in each group withdrew from the study. CONCLUSIONS: D-002 (100 mg/day) improved ultrasonographic findings, indicators of insulin resistance, plasma TAS and clinical evolution on NAFLD patients. Further studies, however, are needed to confirm these results.
Adult
;
Aged
;
Antioxidants/adverse effects/isolation & purification/*therapeutic use
;
Biological Markers/blood
;
Blood Glucose/metabolism
;
Cuba
;
Double-Blind Method
;
Enzymes/blood
;
Fatty Alcohols/adverse effects/isolation & purification/*therapeutic use
;
Fatty Liver/blood/*drug therapy/ultrasonography
;
Female
;
Humans
;
Insulin/blood
;
Lipids/blood
;
Liver/*drug effects/enzymology/ultrasonography
;
Male
;
Middle Aged
;
Prospective Studies
;
Time Factors
;
Treatment Outcome
;
Waxes/*chemistry
2.Omega 3 Fatty Acids and COVID-19:A Comprehensive Review
Donald HATHAWAY III ; Krunal PANDAV ; Madhusudan PATEL ; Adrian RIVA-MOSCOSO ; Bishnu Mohan SINGH ; Aayushi PATEL ; Zar CHI MIN ; Sarabjot SINGH-MAKKAR ; Muhammad KHAWAR SANA ; Rafael SANCHEZ-DOPAZO ; Rockeven DESIR ; Michael Maher MOURAD FAHEM ; Susan MANELLA ; Ivan RODRIGUEZ ; Alina ALVAREZ ; Rafael ABREU
Infection and Chemotherapy 2020;52(4):478-495
The rapid international spread of severe acute respiratory syndrome coronavirus 2 responsible for coronavirus disease 2019 (COVID-19) has posed a global health emergency in 2020. It has affected over 52 million people and led to over 1.29 million deaths worldwide, as of November 13th, 2020. Patients diagnosed with COVID-19 present with symptoms ranging from none to severe and include fever, shortness of breath, dry cough, anosmia, and gastrointestinal abnormalities. Severe complications are largely due to overdrive of the host immune system leading to “cytokine storm”. This results in disseminated intravascular coagulation, acute respiratory distress syndrome, multiple organ dysfunction syndrome, and death. Due to its highly infectious nature and concerning mortality rate, every effort has been focused on prevention and creating new medications or repurposing old treatment options to ameliorate the suffering of COVID-19 patients including the immune dysregulation. Omega-3 fatty acids are known to be incorporated throughout the body into the bi-phospholipid layer of the cell membrane leading to the production of less pro-inflammatory mediators compared to other fatty acids that are more prevalent in the Western diet. In this article, the benefits of omega-3 fatty acids, especially eicosapentaenoic acid and docosahexaenoic acid, including their anti-inflammatory, immunomodulating, and possible antiviral effects have been discussed.
3.Omega 3 Fatty Acids and COVID-19:A Comprehensive Review
Donald HATHAWAY III ; Krunal PANDAV ; Madhusudan PATEL ; Adrian RIVA-MOSCOSO ; Bishnu Mohan SINGH ; Aayushi PATEL ; Zar CHI MIN ; Sarabjot SINGH-MAKKAR ; Muhammad KHAWAR SANA ; Rafael SANCHEZ-DOPAZO ; Rockeven DESIR ; Michael Maher MOURAD FAHEM ; Susan MANELLA ; Ivan RODRIGUEZ ; Alina ALVAREZ ; Rafael ABREU
Infection and Chemotherapy 2020;52(4):478-495
The rapid international spread of severe acute respiratory syndrome coronavirus 2 responsible for coronavirus disease 2019 (COVID-19) has posed a global health emergency in 2020. It has affected over 52 million people and led to over 1.29 million deaths worldwide, as of November 13th, 2020. Patients diagnosed with COVID-19 present with symptoms ranging from none to severe and include fever, shortness of breath, dry cough, anosmia, and gastrointestinal abnormalities. Severe complications are largely due to overdrive of the host immune system leading to “cytokine storm”. This results in disseminated intravascular coagulation, acute respiratory distress syndrome, multiple organ dysfunction syndrome, and death. Due to its highly infectious nature and concerning mortality rate, every effort has been focused on prevention and creating new medications or repurposing old treatment options to ameliorate the suffering of COVID-19 patients including the immune dysregulation. Omega-3 fatty acids are known to be incorporated throughout the body into the bi-phospholipid layer of the cell membrane leading to the production of less pro-inflammatory mediators compared to other fatty acids that are more prevalent in the Western diet. In this article, the benefits of omega-3 fatty acids, especially eicosapentaenoic acid and docosahexaenoic acid, including their anti-inflammatory, immunomodulating, and possible antiviral effects have been discussed.
4.Correlation between magnetic resonance imaging and cone-beam computed tomography for maxillary sinus graft assessment
Fernando Antonio Reis LAURINO ; Isabela Goulart Gil CHOI ; Jun Ho KIM ; Ivan Onone GIALAIN ; Renato FERRAÇO ; Rainer Guilherme HAETINGER ; Otavio Henrique PINHATA-BAPTISTA ; Reinaldo ABDALA-JUNIOR ; Claudio COSTA ; Arthur Rodriguez Gonzalez CORTES
Imaging Science in Dentistry 2020;50(2):93-98
Purpose:
Little is known regarding the accuracy of clinical magnetic resonance imaging (MRI) protocols with acceptable scan times in sinus graft assessment. The aim of this study was to evaluate the correlations between MRI and cone-beam computed tomographic (CBCT) measurements of maxillary sinus grafts using 2 different clinical MRI imaging protocols.
Materials and Methods:
A total of 15 patients who underwent unilateral sinus lift surgery with biphasic calcium phosphate were included in this study. CBCT, T1-weighted MRI, and T2-weighted MRI scans were taken 6 months after sinus lift surgery. Linear measurements of the maximum height and buccolingual width in coronal images, as well as the maximum anteroposterior depth in sagittal images, were performed by 2 trained observers using CBCT and MRI Digital Imaging and Communication in Medicine files. Microcomputed tomography (micro-CT) was also performed to confirm the presence of bone tissue in the grafted area. Correlations between MRI and CBCT measurements were assessed with the Pearson test.
Results:
Significant correlations between CBCT and MRI were found for sinus graft height (T1-weighted, r=0.711 and p<0.05; T2-weighted, r=0.713 and p<0.05), buccolingual width (T1-weighted, r=0.892 and p<0.05; T2-weighted, r=0.956 and p<0.05), and anteroposterior depth (T1-weighted, r=0.731 and p<0.05; T2-weighted, r=0.873 and p<0.05). The presence of bone tissue in the grafted areas was confirmed via micro-CT.
Conclusion
Both MRI pulse sequences tested can be used for sinus graft measurements, as strong correlations with CBCT were found. However, correlations between T2-weighted MRI and CBCT were slightly higher than those between T1-weighted MRI and CBCT.
5.The Philippine Coronavirus Disease 2019 (COVID-19) profile study: Clinical profile and factors associated with mortality of hospitalized patients
Maria Luz Joanna B. Soria ; Leslie Q. Quiwa ; Ma. Kristine Joy S. Calvario ; Jose Eduardo D. Duya ; Rommel B. Punongbayan ; Frederic Ivan L. Ting
Philippine Journal of Internal Medicine 2021;59(1):37-58
Introduction:
The coronavirus disease 2019 (COVID-19) have spread globally and reached the Philippines in late January 2020. This study is the first local and nationwide research on admitted COVID-19 adult patients: their clinic-demographic profiles, managements, and clinical outcomes. We aim to determine the associated factors with mortality among COVID-19 patients.
Methods:
This was a retrospective, multicenter, observational cohort study of rt-PCR confirmed and admitted COVID-19 adult patients in 89 hospitals in the Philippines from February to July, 2020. The data on admission of patient’s demographic, clinical, laboratory, pre-hospital and during hospital treatment management and in-hospital clinical outcomes were gathered. The data were described and analyzed using multiple logistic regression analysis.
Results:
There were 2884 rt-PCR confirmed and admitted COVID-19 adult patients included in the study. Majority were Filipinos (99·4%), with slightly more males (54.4%) than females. 21% were healthcare workers (HCWs). Mortality was higher among non-HCWs at 16% versus 2% among HCWs. 63% of the patients had a co-morbidity, which included hypertension (69%), diabetes mellitus (48%) and chronic kidney disease (26%). The significantly associated factors with mortality in this Philippine cohort were: age >60 years, hypertension as co-morbidity, tachypnea (> 22/minute), WBC count > 10 x 109 /L, and elevated serum lactate dehydrogenase (LDH) (all p<0.05). Elevated serum LDH was the strongest factor associated with mortality (OR of 8.74, p=0.004).
Conclusion
This study identified that age, hypertension, tachypnea, elevated WBC count, and elevated serum LDH were associated with mortality among COVID-19 adult patients and results were consistent with results from studies done in other countries. We recommend that early detection and awareness of exposures and symptoms will improve the management and clinical outcomes of COVID-19 adult patients. Also, a long follow-up of the outcomes of COVID-19 to determine the effectiveness of treatment is recommended for further study.
Philippines
;
Mortality